Vimarsana
Biggest News Aggregation in the World

Common Warrants News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Common Warrants. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Common Warrants Today - Breaking & Trending Today

Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering - Vimarsana News

Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering

BURLINGAME, Calif., May 02, 2024 -- Corvus Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that it has entered into a securities purchase agreement with new...

Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering - Vimarsana News

Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering

Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced public offering...

Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering - Vimarsana News

Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering

Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering

Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing - Vimarsana News

Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing

NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative thera...

Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update - Vimarsana News

Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Palatin's Focus is Solely on the Development of its Melanocortin Receptor (MCR) System Pipeline PL9643 MELODY-1 Pivotal Phase 3 Study in Dry Eye Disease (DED)...